Affinity DataKi: 0.75nMAssay Description:Inhibition of recombinant human activated TAFI incubated for 45 mins using hippuryl-arginine as substrate by spectrophotometryMore data for this Ligand-Target Pair
Affinity DataKi: 3.5nMAssay Description:Inhibition of active form of human recombinant TAFI assessed as substrate turnover every 15 seconds for 30 minsMore data for this Ligand-Target Pair
Affinity DataKi: 4nMAssay Description:Inhibition of human TAFIaMore data for this Ligand-Target Pair
Affinity DataKi: 5.70nMAssay Description:Inhibition of active form of human recombinant TAFI assessed as substrate turnover every 15 seconds for 30 minsMore data for this Ligand-Target Pair
Affinity DataKi: 5.80nMAssay Description:Inhibition of active form of human recombinant TAFI assessed as substrate turnover every 15 seconds for 30 minsMore data for this Ligand-Target Pair
Affinity DataKi: 6.70nMAssay Description:Inhibition of active form of human recombinant TAFI assessed as substrate turnover every 15 seconds for 30 minsMore data for this Ligand-Target Pair
Affinity DataKi: 7.5nMAssay Description:Inhibition of active form of human recombinant TAFI assessed as substrate turnover every 15 seconds for 30 minsMore data for this Ligand-Target Pair
Affinity DataKi: 8.20nMAssay Description:Inhibition of active form of human recombinant TAFI assessed as substrate turnover every 15 seconds for 30 minsMore data for this Ligand-Target Pair
Affinity DataKi: 10nMAssay Description:Inhibition of human TAFIaMore data for this Ligand-Target Pair
Affinity DataKi: 15nMAssay Description:Inhibition of active form of human recombinant TAFI assessed as substrate turnover every 15 seconds for 30 minsMore data for this Ligand-Target Pair
Affinity DataKi: 16nMAssay Description:Inhibition of active form of human recombinant TAFI assessed as substrate turnover every 15 seconds for 30 minsMore data for this Ligand-Target Pair
Affinity DataKi: 46nMAssay Description:Inhibition of human TAFIaMore data for this Ligand-Target Pair
Affinity DataKi: 65nMAssay Description:Inhibition of active form of human recombinant TAFI assessed as substrate turnover every 15 seconds for 30 minsMore data for this Ligand-Target Pair
Affinity DataKi: 70nMAssay Description:Inhibition of human TAFIaMore data for this Ligand-Target Pair
Affinity DataKi: 84nMAssay Description:Inhibition of human TAFIaMore data for this Ligand-Target Pair
Affinity DataKi: 100nMAssay Description:Inhibition of human TAFIaMore data for this Ligand-Target Pair
Affinity DataKi: 111nMAssay Description:Inhibition of human TAFIaMore data for this Ligand-Target Pair
Affinity DataKi: 124nMAssay Description:Inhibition of human TAFIaMore data for this Ligand-Target Pair
Affinity DataKi: 140nMAssay Description:Inhibition of human TAFIaMore data for this Ligand-Target Pair
Affinity DataKi: 140nMAssay Description:Inhibition of human TAFIaMore data for this Ligand-Target Pair
Affinity DataKi: 150nMAssay Description:Inhibition of active form of human recombinant TAFI assessed as substrate turnover every 15 seconds for 30 minsMore data for this Ligand-Target Pair
Affinity DataKi: 160nMAssay Description:Inhibition of human TAFIaMore data for this Ligand-Target Pair
Affinity DataKi: 235nMAssay Description:Inhibition of human TAFIaMore data for this Ligand-Target Pair
Affinity DataKi: 250nMAssay Description:Inhibition of human TAFIaMore data for this Ligand-Target Pair
Affinity DataKi: 269nMAssay Description:Inhibition of human TAFIaMore data for this Ligand-Target Pair
Affinity DataKi: 300nMAssay Description:Inhibition of human TAFIaMore data for this Ligand-Target Pair
Affinity DataKi: 344nMAssay Description:Inhibition of human TAFIaMore data for this Ligand-Target Pair
Affinity DataKi: 407nMAssay Description:Inhibition of active form of human recombinant TAFI assessed as substrate turnover every 15 seconds for 30 minsMore data for this Ligand-Target Pair
Affinity DataKi: 430nMAssay Description:Inhibition of human TAFIaMore data for this Ligand-Target Pair
Affinity DataKi: >700nMAssay Description:Inhibition of human TAFIaMore data for this Ligand-Target Pair
Affinity DataKi: >1.00E+3nMAssay Description:Inhibition of active form of human recombinant TAFI assessed as substrate turnover every 15 seconds for 30 minsMore data for this Ligand-Target Pair
Affinity DataKi: 1.60E+3nMAssay Description:The aromatic compounds screening were characterized by molecular docking as well as by in vitro inhibition assay against carboxypeptidase(CPs) of dif...More data for this Ligand-Target Pair
Affinity DataKi: 1.90E+3nMAssay Description:The aromatic compounds screening were characterized by molecular docking as well as by in vitro inhibition assay against carboxypeptidase(CPs) of dif...More data for this Ligand-Target Pair
Affinity DataKi: 7.40E+3nMAssay Description:The aromatic compounds screening were characterized by molecular docking as well as by in vitro inhibition assay against carboxypeptidase(CPs) of dif...More data for this Ligand-Target Pair
Affinity DataKi: 1.18E+4nMAssay Description:The aromatic compounds screening were characterized by molecular docking as well as by in vitro inhibition assay against carboxypeptidase(CPs) of dif...More data for this Ligand-Target Pair
Affinity DataKi: 1.33E+4nMAssay Description:The aromatic compounds screening were characterized by molecular docking as well as by in vitro inhibition assay against carboxypeptidase(CPs) of dif...More data for this Ligand-Target Pair
Affinity DataKi: 1.43E+4nMAssay Description:The aromatic compounds screening were characterized by molecular docking as well as by in vitro inhibition assay against carboxypeptidase(CPs) of dif...More data for this Ligand-Target Pair
Affinity DataKi: 1.70E+4nMAssay Description:Inhibition of human TAFIaMore data for this Ligand-Target Pair
Affinity DataKi: 2.25E+4nMAssay Description:The aromatic compounds screening were characterized by molecular docking as well as by in vitro inhibition assay against carboxypeptidase(CPs) of dif...More data for this Ligand-Target Pair
Affinity DataKi: 3.20E+4nMAssay Description:The aromatic compounds screening were characterized by molecular docking as well as by in vitro inhibition assay against carboxypeptidase(CPs) of dif...More data for this Ligand-Target Pair
Affinity DataKi: 5.00E+4nMAssay Description:The aromatic compounds screening were characterized by molecular docking as well as by in vitro inhibition assay against carboxypeptidase(CPs) of dif...More data for this Ligand-Target Pair
Affinity DataKi: 1.45E+5nMAssay Description:The aromatic compounds screening were characterized by molecular docking as well as by in vitro inhibition assay against carboxypeptidase(CPs) of dif...More data for this Ligand-Target Pair
Affinity DataKi: 2.20E+5nMAssay Description:The aromatic compounds screening were characterized by molecular docking as well as by in vitro inhibition assay against carboxypeptidase(CPs) of dif...More data for this Ligand-Target Pair
Affinity DataIC50: 0.00200nMAssay Description:Inhibition of human activated TAFI using Hip-Arg as substrate incubated for 10 mins prior to substrate addition measured after 30 mins by spectrophot...More data for this Ligand-Target Pair
Affinity DataIC50: 0.0250nMAssay Description:Inhibition of human activated TAFI using Hip-Arg as substrate incubated for 10 mins prior to substrate addition measured after 30 mins by spectrophot...More data for this Ligand-Target Pair
Affinity DataIC50: 1nMAssay Description:Inhibitory potency against human TAFIa (thrombin-activatable fibrinolysis inhibitor)More data for this Ligand-Target Pair
Affinity DataIC50: 1nMAssay Description:Inhibition of recombinant human activated TAFI incubated for 45 mins using hippuryl-arginine as substrate by spectrophotometryMore data for this Ligand-Target Pair
Affinity DataIC50: 1nMAssay Description:Inhibition of human activated TAFI incubated for 15 mins by microtiter plate reader based assayMore data for this Ligand-Target Pair
Affinity DataIC50: 1.10nMAssay Description:Inhibition of human activated TAFI using Hip-Arg as substrate incubated for 10 mins prior to substrate addition measured after 30 mins by spectrophot...More data for this Ligand-Target Pair
Affinity DataIC50: 1.5nMAssay Description:Inhibition of human plasma activated thrombin-activatable fibrinolysis inhibitor after 10 mins in presence of DTTMore data for this Ligand-Target Pair